Julia Pitts tried all the standard treatment options with her local physicians after she was diagnosed with metastatic uterine cancer in 2015. When they were no longer effective, she decided to seek out clinical trial options at MD Anderson.
Her cancer had mutations in the KRAS gene, which made her a candidate for an investigational targeted therapy called sotorasib, or AMG 510, which blocks the mutant KRAS protein. After roughly...
A study published in JAMA comparing adverse event outcomes by treatment type for patients with localized prostate cancer reveals most...
MD Anderson researchers have developed the first machine learning algorithm to predict acute toxicities in patients receiving radiation therapy...
Immunology research to investigate the mechanisms of a new aerosol treatment, which induces an innate immune response to protect against pathogens that cause pneumonia, asthma, and other lung diseases, has earned major funding from the National Heart, Lung, and Blood Institute.
“This research will help protect patients who are most vulnerable to pneumonia, especially patients with cancer,” said Scott Evans, M.D., the principal...
Over the past decade, immune checkpoint inhibitors have shown success in treating several types of cancer, including melanoma, non-small cell...
MD Anderson Cancer Center and Accelerator Life Science Partners, a leading life science investment and management firm, have launched Magnolia...
Cancer patients who have undergone lymph node removal or radiation therapy as part of cancer treatment know all too well the pain and discomfort...
A type of functional brain training known as neurofeedback shows promise in reducing symptoms of chemotherapy-induced nerve damage, or neuropathy...
The 90 percent of cancer patients who experience pain due to nerve damage caused by tumors, surgery, chemotherapy or radiation may someday...